Assertio's Small Asset Acquisition Strategy Is Risky, But It May Pay Off

Stock Information for Spectrum Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Spectrum Pharmaceuticals Inc.

Assertio to Participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025
Assertio Reports First Quarter 2025 Financial Results
Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025
iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025
Assertio to Participate in the iAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025
Assertio Reports Fourth Quarter and Full Year 2024 Financial Results
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Assertio Holdings, Inc. (NASDAQ: ASRT); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.